John Overdeck’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,684
Closed -$324K 5171
2026
Q1
$324K Buy
+9,684
New +$360K ﹤0.01% 4025
2025
Q3
Sell
-50,000
Closed -$1.62M 3723
2025
Q2
$1.62M Buy
+50,000
New +$1.43M ﹤0.01% 1967
2025
Q1
Sell
-39,800
Closed -$1.14M 3292
2024
Q4
$1.14M Buy
+39,800
New +$1.16M ﹤0.01% 2092
2024
Q2
Sell
-27,600
Closed -$763K 3123
2024
Q1
$763K Sell
27,600
-6,100
-18% -$159K ﹤0.01% 2122
2023
Q4
$821K Buy
+33,700
New +$766K ﹤0.01% 2191
2023
Q3
Sell
-31,900
Closed -$816K 3031
2023
Q2
$816K Buy
+31,900
New +$756K ﹤0.01% 2067

Other funds holding FFTY

John Overdeck's FFTY Position: Q2 2026 in Review

John Overdeck sold out of CapForce IBD 50 ETF (FFTY) in Q2 2026, closing a stake of 9,684 shares — an estimated $324K sold.

John Overdeck first reported a position in FFTY in Q2 2023 and held it in 6 quarters. The position peaked at $1.62M in Q2 2025. 33 funds tracked by Wall St. Rank hold FFTY as of Q2 2026.

  • John Overdeck reported no remaining CapForce IBD 50 ETF position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 9,684 CapForce IBD 50 ETF shares in Q2 2026, an estimated $324K.
  • John Overdeck first reported a position in CapForce IBD 50 ETF in Q2 2023 and held it in 6 quarters.
  • John Overdeck's CapForce IBD 50 ETF position peaked at $1.62M in Q2 2025.
  • 33 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.